☰

Michael D. Rosu-Myles, Ph.D. - Publications

Affiliations: 
2004 The University of Western Ontario (Canada) 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Gobin J, Muradia G, Mehic J, Westwood C, Couvrette L, Stalker A, Bigelow S, Luebbert CC, Bissonnette FS, Johnston MJW, Sauvé S, Tam RY, Wang L, Rosu-Myles M, Lavoie JR. Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell. Stem Cell Research & Therapy. 12: 127. PMID 33579358 DOI: 10.1186/s13287-021-02190-3  0.357
2019 Munshi A, Mehic J, Creskey M, Gobin J, Gao J, Rigg E, Muradia G, Luebbert CC, Westwood C, Stalker A, Allan DS, Johnston MJW, Cyr T, Rosu-Myles M, Lavoie JR. A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles. Stem Cell Research & Therapy. 10: 401. PMID 31852509 DOI: 10.1186/s13287-019-1516-2  0.319
2019 Aldreiwish A, Muradia G, Gagne R, Beal M, Yauk C, Allan DS, Diaz de la Guardia R, Menendez P, Rosu-Myles M, Lavoie J.. "Identification of Mechanisms By Which Mesenchymal Stem/Stromal Cells Contribute to Acute Myeloid Leukemia" Blood. 134: 5194-5194. DOI: 10.1182/blood-2019-122558  0.353
2018 Díaz de la Guardia R, Lopez-Millan B, Roca-Ho H, Bueno C, Gutiérrez-Agüera F, Luis Fuster J, Anguita E, Zanetti S, Vives S, Nomdedeu J, Sackstein R, Lavoie J, Gónzalez-Rey E, Delgado M, Rosu-Myles M, et al. Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis. Haematologica. PMID 30237260 DOI: 10.3324/haematol.2018.196568  0.414
2018 Munshi A, Rigg E, Mehic J, Rosu-Myles M, Lavoie J. Comparative study of hypoxic and normoxic preconditioned mesenchymal stem cell derived extracellular vesicles and their therapeutic implications Cytotherapy. 20: S23. DOI: 10.1016/J.JCYT.2018.02.052  0.411
2018 Lavoie J, Rigg E, Munshi A, Mehic J, Muradia G, Rosu-Myles M. Characterization of leukemia-derived extracellular vesicles and subsequent effects on mesenchymal stem cell phenotype Cytotherapy. 20: S22. DOI: 10.1016/j.jcyt.2018.02.050  0.428
2017 Diaz de la Guardia R, Lopez-Millan B, Lavoie JR, Bueno C, Castaño J, Gómez-Casares M, Vives S, Palomo L, Juan M, Delgado J, Blanco ML, Nomdedeu J, Chaparro A, Fuster JL, Anguita E, ... Rosu-Myles M, et al. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes. Stem Cell Reports. PMID 28528702 DOI: 10.1016/j.stemcr.2017.04.019  0.377
2016 Lavoie JR, Creskey MC, Muradia G, Bell GI, Sherman SE, Gao J, Stewart DJ, Cyr TD, Hess DA, Rosu-Myles M. EMILIN-1 and ILK are Novel Markers of Islet Regenerative Function in Human Multipotent Mesenchymal Stromal Cells. Stem Cells (Dayton, Ohio). PMID 27090767 DOI: 10.1002/stem.2385  0.368
2016 Lavoie J, Kunkel J, Saba J, Muradia G, Westwood C, Viner R, Diaz de la Guardia R, Schroeder T, Rodriguez R, Menendez P, Rosu-Myles M. Generation of Quantitative Proteomic and Glycoproteomic Profiles Specific to Transformed Mesenchymal Stem Cells Cytotherapy. 18: S24. DOI: 10.1016/J.JCYT.2016.03.069  0.344
2016 Lavoie J, Rodriguez R, Kunkel J, Westwood C, Muradia G, Saba J, Viner R, Schroeder T, Guardia Rdl, Menendez P, Rosu-Myles M. Candidate biomarkers of transformed mesenchymal stromal/stem cells by quantitative proteomics and glycoproteomics Experimental Hematology. 44: S86-S87. DOI: 10.1016/J.EXPHEM.2016.06.176  0.355
2015 Le Y, Fraineau S, Chandran P, Sabloff M, Brand M, Lavoie JR, Gagne R, Rosu-Myles M, Yauk CL, Richardson RB, Allan DS. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia. Stem Cell Reviews. PMID 26649729 DOI: 10.1007/s12015-015-9639-z  0.362
2015 Chandran P, Le Y, Li Y, Sabloff M, Mehic J, Rosu-Myles M, Allan DS. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors. Leukemia Research. 39: 486-93. PMID 25703353 DOI: 10.1016/j.leukres.2015.01.013  0.468
2014 Hashem AM, Gravel C, Chen Z, Yi Y, Tocchi M, Jaentschke B, Fan X, Li C, Rosu-Myles M, Pereboev A, He R, Wang J, Li X. CD40 ligand preferentially modulates immune response and enhances protection against influenza virus. Journal of Immunology (Baltimore, Md. : 1950). 193: 722-34. PMID 24928989 DOI: 10.4049/jimmunol.1300093  0.314
2014 Bueno C, Roldan M, Anguita E, Romero-Moya D, Martín-Antonio B, Rosu-Myles M, del Cañizo C, Campos F, García R, Gómez-Casares M, Fuster JL, Jurado M, Delgado M, Menendez P. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica. 99: 1168-75. PMID 24727813 DOI: 10.3324/haematol.2014.103580  0.395
2014 Rubio R, Abarrategi A, Garcia-Castro J, Martinez-Cruzado L, Suarez C, Tornin J, Santos L, Astudillo A, Colmenero I, Mulero F, Rosu-Myles M, Menendez P, Rodriguez R. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells. Stem Cells (Dayton, Ohio). 32: 1136-48. PMID 24446210 DOI: 10.1002/stem.1647  0.325
2014 Menendez P, Rodriguez R, Delgado M, Rosu-Myles M. Human bone marrow mesenchymal stem cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation Experimental Hematology. 42: S49. DOI: 10.1016/J.EXPHEM.2014.07.184  0.338
2013 Rodriguez R, Tornin J, Suarez C, Astudillo A, Rubio R, Yauk C, Williams A, Rosu-Myles M, Funes JM, Boshoff C, Menendez P. Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation. Stem Cells (Dayton, Ohio). 31: 2061-72. PMID 23836491 DOI: 10.1002/stem.1472  0.386
2013 Lavoie JR, Rosu-Myles M. Uncovering the secretes of mesenchymal stem cells Biochimie. 95: 2212-2221. PMID 23810910 DOI: 10.1016/j.biochi.2013.06.017  0.321
2013 Humeniuk R, Rosu-Myles M, Fares J, Koller R, Bies J, Wolff L. The role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate. Blood Cancer Journal. 3: e99. PMID 23359317 DOI: 10.1038/Bcj.2012.44  0.422
2013 Rosu-Myles M, McCully J, Fair J, Mehic J, Menendez P, Rodriguez R, Westwood C. The globoseries glycosphingolipid SSEA-4 is a marker of bone marrow-derived clonal multipotent stromal cells in vitro and in vivo. Stem Cells and Development. 22: 1387-97. PMID 23330736 DOI: 10.1089/scd.2012.0547  0.448
2013 Humeniuk R, Rosu-Myles M, Wolff L. Abstract 1973: Tumor suppressor p15Ink4b determines cell fate of hematopoietic progenitors: Implications for development of human blood disorders. Cancer Research. 73: 1973-1973. DOI: 10.1158/1538-7445.Am2013-1973  0.466
2012 Rubio R, Gutierrez-Aranda I, Sáez-Castillo AI, Labarga A, Rosu-Myles M, Gonzalez-Garcia S, Toribio ML, Menendez P, Rodriguez R. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development. Oncogene. 32: 4970-80. PMID 23222711 DOI: 10.1038/onc.2012.507  0.354
2012 Rosu-Myles M, She YM, Fair J, Muradia G, Mehic J, Menendez P, Prasad SS, Cyr TD. Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells. Plos One. 7: e38954. PMID 22719999 DOI: 10.1371/journal.pone.0038954  0.506
2012 Boulanger CA, Bruno RD, Rosu-Myles M, Smith GH. The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate. Stem Cells and Development. 21: 948-54. PMID 21649558 DOI: 10.1089/Scd.2011.0148  0.471
2010 Rosu-Myles M, Fair J, Pearce N, Mehic J. Non-multipotent stroma inhibit the proliferation and differentiation of mesenchymal stromal cells in vitro. Cytotherapy. 12: 818-30. PMID 20662608 DOI: 10.3109/14653249.2010.501785  0.471
2008 Rosu-Myles M, Wolff L. p15Ink4b: dual function in myelopoiesis and inactivation in myeloid disease. Blood Cells, Molecules & Diseases. 40: 406-9. PMID 18029205 DOI: 10.1016/J.Bcmd.2007.09.005  0.329
2007 Rosu-Myles M, Taylor BJ, Wolff L. Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors. Experimental Hematology. 35: 394-406. PMID 17309820 DOI: 10.1016/J.Exphem.2006.11.005  0.495
2005 Rosu-Myles M, Stewart E, Trowbridge J, Ito CY, Zandstra P, Bhatia M. A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis. Journal of Cell Science. 118: 4343-52. PMID 16144866 DOI: 10.1242/Jcs.02555  0.616
2005 Rosu-Myles M, Wolff L. p15Ink4b Maintains Normal Levels of Granulocyte-Macrophage Progenitors In Vivo . Blood. 106: 2280-2280. DOI: 10.1182/Blood.V106.11.2280.2280  0.442
2003 Rosu-Myles M, Bhatia M. SDF-1 enhances the expansion and maintenance of highly purified human hematopoietic progenitors. The Hematology Journal : the Official Journal of the European Haematology Association / Eha. 4: 137-45. PMID 12750733 DOI: 10.1038/Sj.Thj.6200233  0.663
2002 Hess DA, Levac KD, Karanu FN, Rosu-Myles M, White MJ, Gallacher L, Murdoch B, Keeney M, Ottowski P, Foley R, Chin-Yee I, Bhatia M. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor. Blood. 100: 869-78. PMID 12130497 DOI: 10.1182/Blood.V100.3.869  0.63
2000 Rosu-Myles M, Gallacher L, Murdoch B, Hess DA, Keeney M, Kelvin D, Dale L, Ferguson SS, Wu D, Fellows F, Bhatia M. The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proceedings of the National Academy of Sciences of the United States of America. 97: 14626-31. PMID 11121064 DOI: 10.1073/Pnas.97.26.14626  0.622
2000 Rosu-Myles M, Khandaker M, Wu DM, Keeney M, Foley SR, Howson-Jan K, Chin Yee I, Fellows F, Kelvin D, Bhatia M. Characterization of chemokine receptors expressed in primitive blood cells during human hematopoietic ontogeny Stem Cells. 18: 374-381. PMID 11007922 DOI: 10.1634/Stemcells.18-5-374  0.665
Show low-probability matches.